Gastroenterology: Microsatellite Instability in Interval Colon Cancers (abstract)

Gastroenterology: "Microsatellite Instability in Interval Colon Cancers"

Right Drug, Right Patient, Right Now (comment: well, not exactly true)

Right Drug, Right Patient, Right Now — AskBig.: "Right Drug, Right Patient, Right Now"

The Scientist : "Silent" mutations are not always silent

The Scientist : "Silent" mutations are not always silent

2006 UK Safer Health Care: Relationship between patient complaints and surgical complications

ComplicationsAndComplaints.pdf (application/pdf Object)

Moral Priorities in a Teaching Hospital

Moral Priorities in a Teaching Hospital

Entrez PubMed

Entrez PubMed: "Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary."

Emerging Themes in Epidemiology | Full text | Identifying related cancer types based on their incidence among people with multiple cancers

Emerging Themes in Epidemiology | Full text | Identifying related cancer types based on their incidence among people with multiple cancers

2006 Waiting Your Turn - Fraser Institute

wyt2006.pdf (application/pdf Object)

Paying More Getting Less 2006 Fraser Institute

PayingMoreGettingLess2006.pdf (application/pdf Object)

2007 JCO Peer Mentoring and Survivors’ Stories for Cancer Patients

163.pdf (application/pdf Object)

How Good Is Canadian Health Care 2006? Fraser Institute report

HowGoodHealthCare2006.pdf (application/pdf Object)

Association of Lymphadenectomy and Survival in Stage I Ovarian Cancer Patients -- Chan et al. 109 (1): 12 -- Obstetrics & Gynecology

Association of Lymphadenectomy and Survival in Stage I Ovarian Cancer Patients -- Chan et al. 109 (1): 12 -- Obstetrics & Gynecology

2006 Treatment Issues in Clear Cell Carcinoma of the Ovary:

1089.pdf (application/pdf Object)

Moral Emotions and Moral Behavior - Annual Review of Psychology, 58(1):345 - Abstract

Moral Emotions and Moral Behavior - Annual Review of Psychology, 58(1):345 - Abstract

Minimizing delays in ovarian cancer diagnosis: an expansion of Andersen's model of 'total patient delay' -- Evans et al., 10.1093/fampra/cml063 -- Fam

Minimizing delays in ovarian cancer diagnosis: an expansion of Andersen's model of 'total patient delay' -- Evans et al., 10.1093/fampra/cml063 -- Family Practice

Google - Internet Over Internists? | theledger.com

Google - Internet Over Internists? | theledger.com

Pharmacologic opportunities for the chemoprevention of ovarian cancer. -- Rodriguez et al. 2006 (3): CS18-03 -- AACR Meeting Abstracts

Pharmacologic opportunities for the chemoprevention of ovarian cancer. -- Rodriguez et al. 2006 (3): CS18-03 -- AACR Meeting Abstracts

FDA Proposes Rules Overhaul to Expand Availability of Experimental Drugs

FDA Proposes Rules Overhaul to Expand Availability of Experimental Drugs

NCI Cancer Bulletin for December 12, 2006 (HTML) - National Cancer Institute

NCI Cancer Bulletin for December 12, 2006 (HTML) - National Cancer Institute

Entrez PubMed

Entrez PubMed

Entrez PubMed

Entrez PubMed

ScienceDirect - Gynecologic Oncology : Does smoking increase risk of ovarian cancer? A systematic review

ScienceDirect - Gynecologic Oncology : Does smoking increase risk of ovarian cancer? A systematic review

Managing Chemotherapy Side Effects For Dummies

Managing Chemotherapy Side Effects For Dummies

CancerWise - December 2006 - Trial Studies Ovarian Cancer Screening Test

CancerWise - December 2006 - Trial Studies Ovarian Cancer Screening Test

Trial Studies Ovarian Cancer Screening Test
Healthy Postmenopausal Women Being Recruited

Should women be screened for ovarian cancer? Researchers hope to answer that question through a new study in which blood and urine samples from healthy, postmenopausal women are collected and analyzed.

Goal of study

M. D. Anderson researchers conducting the Low-Risk Ovarian Cancer Study hope the clinical trial and others like it one day may lead to a more effective screening test to increase early detection of the disease.

“Unfortunately, there’s no effective screening test, like the mammogram or colonoscopy, to detect ovarian cancer at an early stage when the chance of cure is greatest,” says Karen Lu, M.D., associate professor in M. D. Anderson’s Department of Gynecologic Oncology. “As a result, more than two-thirds of all ovarian cancers are found at an advanced stage.”

The purpose of the study is to not only evaluate a blood marker called CA-125 over a period of time, but also to create new markers for ovarian cancer detection. Urine also will be collected so that its proteins can be used to help create new markers.

Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings -- Connor and McDiarmid 56 (6): 354 -- CA: A Cancer Journal for Clin

Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings -- Connor and McDiarmid 56 (6): 354 -- CA: A Cancer Journal for Clinicians

ScienceDirect - Gynecologic Oncology : Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?

ScienceDirect - Gynecologic Oncology : Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?

ScienceDirect - Gynecologic Oncology : Long-term outcomes following conservative surgery for borderline tumor of the ovary: A large population-based s

ScienceDirect - Gynecologic Oncology : Long-term outcomes following conservative surgery for borderline tumor of the ovary: A large population-based study

ScienceDirect - Gynecologic Oncology : Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer

ScienceDirect - Gynecologic Oncology : Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer

ScienceDirect - Gynecologic Oncology : Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial pr

ScienceDirect - Gynecologic Oncology : Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: A prospective cohort study: "Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: A prospective cohort study"

2006 The Epidemiology of Second Primary Cancers

1055-9965.EPI-06-0414v1.pdf (application/pdf Object)

Resource and Time Commitment of Treating Anemia in Cancer Patients

Resource and Time Commitment of Treating Anemia in Cancer Patients

Whose Opinion Counts? -- Loprinzi et al. 24 (33): 5183 -- Journal of Clinical Oncology

Whose Opinion Counts? -- Loprinzi et al. 24 (33): 5183 -- Journal of Clinical Oncology